+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-01-13Number of Pages: 101

Parenteral Nutrition Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

The progress of the global parenteral nutrition market is based on the high prevalence of chronic conditions across the globe. The rise in cancer, AIDS, diabetes, Crohn’s disease, gastro-intestinal disorders, and short bowel syndrome cases has also led a growth in the consumption of parenteral nutrition in the recent years. The World Health Organization (WHO) affirmed this fact with statistics indicating that there will be a 70% rise in the number of new cancer cases between 2025 and 2035. The Crohn’s & Colitis Foundation of America also provided grim figures indicating that there will be 70,000 new cases of Crohn’s disease each year. Thus, the rising health complications will propel the demand for parenteral nutrition across health facilities.

These supportive factors are expected to create an opportunity for this market, which will be worth US$6.9 bn by 2023 as compared to US$4.1 bn in 2014. Between the years 2015 and 2023, this market is expected to expand at a CAGR of 5.7%.

North America Accounted for Over 40% of the Parenteral Nutrition Market in 2014

North America was the leading geographical segment in the global parenteral nutrition market as of 2014, accounting for nearly 40.1% share. The high rate of approvals from the U.S. FDA and supportive insurance policies that cover expenditure on parenteral nutrition are expected to keep this region in the leading position during the forecast period. The North America parenteral nutrition market that comprises the U.S. and Canada will also be driven by rising number diabetes and cancer cases. Furthermore, companies are also trying to expand their operations in Canada to gain a stronger foothold by meeting the unmet needs of the patients.

Meanwhile, the parenteral nutrition market in Asia Pacific is expected to surge at the highest pace of 7.3% CAGR between 2015 and 2023. The emerging economies and developing pharmaceutical markets of countries such as China, India, Indonesia, Singapore, Taiwan, and Thailand amongst others are expected to encourage the growth of this market within Asia Pacific. The rising cases of preterm birth, which leads to malnutrition is the prime reason for rising consumption of parenteral nutrition in Asia Pacific.

Single Dose Amino Acid Solutions Nutrients is Most Attractive Product Segment

Out of all the products available in the global parenteral nutrition market, the single dose amino acid solutions nutrient segment captured a significant share of 34.14% in 2014. Research indicates that this segment will be the leading nutrient segment as several leading players are introducing unique amino acid-based PN products. The abundant availability of these products is expected to be the main reason for their soaring success in the forecast period. Reports also suggest that the parenteral lipid emulsion nutrient segment will grow at the highest CAGR of 6.2% amongst all other nutrient segments between 2015 and 2023.

The leading players shaping the vendor landscape of the global parenteral nutrition market are Sichuan Kelun Pharmaceutical Co., Ltd., Allergan plc (Actavis plc), Fresenius SE & Co. KGaA, Grifols S.A., Baxter International, Inc., Claris Lifesciences Limited, and B. Braun Melsungen AG, Pfizer, Inc. (Hospira, Inc.) amongst others. Companies are trying to seek approvals for their new parenteral nutrition formulations from concerned authorities such as the U.S. FDA to launch new products in the market. This effort is focused at both grabbing new market shares and providing for the deficit of parental nutrition in developing regions.

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Parenteral Nutrition Market: Market Snapshot
2.2 Global Parenteral Nutrition Market Revenue, by Type of Nutrient, 2014 (US$ Mn)
2.4 Global Parenteral Nutrition Market Share, by Geography (Value %)

Chapter 3 Global Parenteral Nutrition Market– Industry Analysis
3.1 Introduction
3.2 Market Dynamics
       3.2.1 Market Driver
                3.2.1.1 Increase in incidence of chronic diseases
                3.2.1.2 Rise in cases of malnutrition
                3.2.1.3 Approvals of novel parenteral nutrition combinations
                3.2.1.4 Aging population
       3.2.2 Market Restraint
                3.2.2.1 Side effects or complications related to parenteral nutrition products
       3.2.3 Market Opportunity
                3.2.3.1 Expanding footprint in emerging nations that offer sustained growth opportunities
3.3 Porter’s Five Forces Analysis: Global Parenteral Nutrition Market
3.4 Event Impact Analysis: Global Parenteral Nutrition Market
3.5 Market Attractiveness Analysis: Global Parenteral Nutrition Market
3.6 Global Market Share – Parenteral Nutrition Market (2014) (%)
       3.6.1 North America Market Share – Parenteral Nutrition Market (2014) (%)
       3.6.2 Europe Market Share – Parenteral Nutrition Market (2014) (%) 
       3.6.3 Asia Pacific Market Share – Parenteral Nutrition Market (2014) (%)
       3.6.4 Latin America Market Share – Parenteral Nutrition Market (2014) (%)
       3.6.5 Middle East & Africa Market Share – Parenteral Nutrition Market (2014) (%)
       3.6.6 Market Share - Carbohydrates Parenteral Nutrition Market (2014) (%)
       3.6.7  Market Share - Parenteral Lipid Emulsion Parenteral Nutrition Market (2014) (%) 
       3.6.8  Market Share - Single Dose Amino Acids Parenteral Nutrition Market (2014) (%) 
       3.6.9 Market Share - Other Parenteral Nutrition Products Market (2014) (%) 

Chapter 4 Market Segmentation - By Type of Nutrient
4.1 Introduction
4.2 Global Parenteral Nutrition Market Revenue, by Types of Nutrient, 2013–2023, (US$ Mn)
       4.2.1 Global Carbohydrates Market Revenue, 2013–2023, (US$ Mn)
       4.2.2 Global Parenteral Lipid Emulsions Market Revenue, 2013–2023, (US$ Mn)
       4.2.3  Global Single Dose Amino Acid Solutions Market Revenue, 2013–2023, (US$ Mn)
       4.2.4 Global Trace Elements Market Revenue, 2013–2023, (US$ Mn)
       4.2.5 Global Vitamins and Minerals Market Revenue, 2013–2023, (US$ Mn)

Chapter 5 Market Segmentation – By Geography
5.1 Global Parenteral Nutrition Market Revenue, by Geography, 2013–2023 (US$ Mn)
5.2 North America Parenteral Nutrition Market Revenue, by Country, 2013–2023 (US$ Mn)
5.3 Europe Parenteral Nutrition Market, by Country, 2013–2023 (US$ Mn)
5.4 Asia Pacific Parenteral Nutrition Market Revenue, by Country, 2013–2023 (US$ Mn)
5.5 Latin America Parenteral Nutrition Market Revenue, by Country, 2013–2023 (US$ Mn)
5.6 Middle East & Africa Parenteral Nutrition Market Revenue, by Country, 2013–2023 (US$ Mn)

Chapter 6 Recommendations
6.1 Expand presence in developing economies
6.2 Increase in research and development activities
6.3 Long-term contract with hospitals and community care centers

Chapter 7 Company Profiles
7.1 Allergan plc (Actavis plc)
7.2 Baxter International, Inc.
7.3 B. Braun Melsungen AG
7.4 Claris Lifesciences Limited
7.5 Fresenius SE & Co. KGaA
7.6 Grifols S.A.
7.7 Pfizer, Inc. (Hospira, Inc.)
7.8 Sichuan Kelun Pharmaceutical Co., Ltd.

Parenteral nutrition refers to the intravenous administration of specialized nutrition solutions such as carbohydrates, single dose amino acids, parenteral lipid emulsions, vitamins and trace elements. This administration method requires when patient’s gastrointestinal track is not working or patients is not adequately nourished by oral or enteral route. This report studies the global parenteral nutrition market in a view of different types of nutrient i.e. carbohydrates, parenteral lipid emulsion, single dose amino acid solutions, vitamins and minerals and trace elements. The report comprises an elaborate executive summary, which includes a market snapshot that provides market dynamics of various segments and sub-segments that are included in the report in a precise manner. Moreover, executive summary comprises waterfall diagram, which reflects the market size of various segments in descending order.

A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global parenteral nutrition market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter’s Five Force analysis, event impact analysis and market attractiveness analysis. Additionally, market share analysis in a view of different geographies (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) and different parenteral nutrients (carbohydrates, parenteral lipid emulsion, single dose amino acid solutions, vitamins and minerals and trace elements) have also been covered under the scope of the report.

Based on type of nutrient, the global parenteral nutrition market has been has been extensively analyzed into carbohydrates, single dose amino acid solutions, parenteral lipid emulsion, trace elements, vitamins and minerals. The market size and forecast in terms of USD million for each type of nutrient has been provided for the period from 2013 to 2023. The report on the parenteral nutrition market also provides compound annual growth rate (CAGR %) for each of the market segments mentioned above for the forecast period from 2015 to 2023, considering 2014 as the base year.

Geographically, the parenteral nutrition market been categorized into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA) which are further divided based on the respective countries. The market size and forecast for each of these regions and countries have been provided for the period from 2013 to 2023 along with CAGR (%) for the forecast period from 2013 to 2023. The research study also incorporates the competitive scenario of major players in these regions.

A list of recommendations has been provided for new entrants to help establish a strong presence and for existing market players to increase their market shares. The report concludes with the profiles of major players in the parenteral nutrition market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Allergan plc (Actavis plc), Baxter International, Inc., B. Braun Melsungen AG, Claris Lifesciences Limited, Fresenius SE & Co. KGaA, Grifols S.A., Pfizer, Inc. (Hospira, Inc.) and others.

The global parenteral nutrition market is segmented as follows:

  • Global Parenteral Nutrition Market, By Type of Nutrient
    • Carbohydrates
    • Parenteral Lipid Emulsion
    • Single Dose Amino Acid Solutions
    • Trace Elements
    • Vitamins and Minerals
  • Global Parenteral Nutrition Market, by Geography
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • France
      • U.K.
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • Taiwan
      • South Korea
      • Rest of APAC
    • Latin America (LATAM)
      • Argentina
      • Mexico
      • Rest of LATAM
    • Middle East and Africa (MEA)
      • Turkey
      • Rest of MEA